2.51
price down icon1.95%   -0.05
pre-market  プレマーケット:  2.51  
loading
前日終値:
$2.56
開ける:
$2.53
24時間の取引高:
3.90M
Relative Volume:
0.69
時価総額:
$854.06M
収益:
-
当期純損益:
$-75.80M
株価収益率:
-7.1714
EPS:
-0.35
ネットキャッシュフロー:
$-68.07M
1週間 パフォーマンス:
+12.05%
1か月 パフォーマンス:
+22.44%
6か月 パフォーマンス:
-0.40%
1年 パフォーマンス:
-30.47%
1日の値動き範囲:
Value
$2.47
$2.62
1週間の範囲:
Value
$2.24
$2.62
52週間の値動き範囲:
Value
$1.54
$3.97

Nuvation Bio Inc Stock (NUVB) Company Profile

Name
名前
Nuvation Bio Inc
Name
セクター
Healthcare (1161)
Name
電話
(415) 754-3517
Name
住所
357 TEHAMA STREET, FLOOR 3, SAN FRANCISCO
Name
職員
273
Name
Twitter
Name
次回の収益日
2025-03-05
Name
最新のSEC提出書
Name
NUVB's Discussions on Twitter

NUVB を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
NUVB
Nuvation Bio Inc
2.51 799.62M 0 -75.80M -68.07M -0.35
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
472.27 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
564.64 61.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.00 42.46B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.74 35.22B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
296.46 31.99B 3.81B -644.79M -669.77M -6.24

Nuvation Bio Inc Stock (NUVB) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-04-23 開始されました Citizens JMP Mkt Outperform
2024-03-27 アップグレード Jefferies Hold → Buy
2024-03-26 アップグレード BTIG Research Neutral → Buy
2023-01-06 ダウングレード Jefferies Buy → Hold
2022-08-02 ダウングレード BMO Capital Markets Outperform → Market Perform
2022-08-02 ダウングレード BTIG Research Buy → Neutral
2022-05-04 開始されました H.C. Wainwright Buy
2021-10-15 再開されました BTIG Research Buy
2021-04-06 開始されました RBC Capital Mkts Outperform
2021-03-08 開始されました BMO Capital Markets Outperform
2021-03-08 開始されました BTIG Research Buy
2021-03-08 開始されました Cowen Outperform
2021-03-08 開始されました Jefferies Buy
2021-03-08 開始されました Wedbush Outperform
すべてを表示

Nuvation Bio Inc (NUVB) 最新ニュース

pulisher
Jul 24, 2025

Nuvation Bio to Report Second Quarter 2025 Financial Results and Provide Business Update on August 7, 2025 - BioSpace

Jul 24, 2025
pulisher
Jul 23, 2025

What drives Nuvation Bio Inc. stock priceConsistent high-performance stocks - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Is Nuvation Bio Inc. a good long term investmentFree Consultation - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Nuvation Bio Inc. Stock Analysis and ForecastFree Stock Index Interpretation - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

What analysts say about Nuvation Bio Inc. stockTremendous gains - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 21, 2025

Bullish Nuvation Bio Insiders Loaded Up On US$2.31m Of Stock - 富途牛牛

Jul 21, 2025
pulisher
Jul 18, 2025

Nuvation Bio’s Phase 2 Study on Safusidenib: A Potential Breakthrough for IDH1 Mutant Glioma - TipRanks

Jul 18, 2025
pulisher
Jul 18, 2025

Will Nuvation Bio Inc. stock benefit from interest rate changesLong Term Low Risk Growth - Newser

Jul 18, 2025
pulisher
Jul 18, 2025

Is Nuvation Bio Inc. stock a good hedge against inflationFree Investing Community - Newser

Jul 18, 2025
pulisher
Jul 17, 2025

Why Nuvation Bio Inc. stock attracts strong analyst attentionLow Risk Entry Points - beatles.ru

Jul 17, 2025
pulisher
Jul 16, 2025

Nuvation Bio's Mysterious 5% Surge: A Deep Dive into the Unseen Drivers - AInvest

Jul 16, 2025
pulisher
Jul 15, 2025

What makes Nuvation Bio Inc. stock price move sharplyIntraday Trade Ideas - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Nuvation Bio Inc. stock performs during market volatilityFree Top Growth Stock Recommendations - Newser

Jul 15, 2025
pulisher
Jul 11, 2025

All You Need to Know About Nuvation Bio (NUVB) Rating Upgrade to Buy - MSN

Jul 11, 2025
pulisher
Jul 10, 2025

Cancer Innovation Accelerates as Funding Cuts Loom and Biotechs Step Up - Quantisnow

Jul 10, 2025
pulisher
Jul 09, 2025

Nuvation Bio's 16% Surge: A Deep Dive Into the Unseen Drivers - AInvest

Jul 09, 2025
pulisher
Jul 09, 2025

Nuvation Bio's 11% Spike: A Deep Dive into the Unseen Drivers - AInvest

Jul 09, 2025
pulisher
Jul 09, 2025

Nuvation Bio’s 7% Surge: A Technical and Market Flow Deep-Dive - AInvest

Jul 09, 2025
pulisher
Jul 07, 2025

Nuvation Bio Inc. (NYSE:NUVB) Receives Consensus Recommendation of “Buy” from Brokerages - Defense World

Jul 07, 2025
pulisher
Jul 07, 2025

Nuvation Bio’s SWOT analysis: IBTROZI approval boosts stock prospects By Investing.com - Investing.com Nigeria

Jul 07, 2025
pulisher
Jul 06, 2025

Nuvation Bio’s SWOT analysis: IBTROZI approval boosts stock prospects - Investing.com

Jul 06, 2025
pulisher
Jul 06, 2025

Positive week for Nuvation Bio Inc. (NYSE:NUVB) institutional investors who lost 31% over the past year - simplywall.st

Jul 06, 2025
pulisher
Jul 02, 2025

RBC Capital Lowers PT on Nuvation Bio (NUVB) to $6 But Keeps a Buy Rating - MSN

Jul 02, 2025
pulisher
Jun 30, 2025

JMP Maintains “Market Outperform” on Nuvation (NUVB) for IBTROZI Launch Plans - MSN

Jun 30, 2025
pulisher
Jun 30, 2025

Nuvation Bio Inc.(NYSE: NUVB) added to Russell 2500 Growth Index - MarketScreener

Jun 30, 2025
pulisher
Jun 29, 2025

Nuvation Bio Inc.(NYSE: NUVB) added to Russell 2000 Growth Index - MarketScreener

Jun 29, 2025
pulisher
Jun 29, 2025

Digging for Diamonds in Biotech: Why Insider Buys Signal Opportunity in Nuvation Bio and Ardelyx - AInvest

Jun 29, 2025
pulisher
Jun 28, 2025

NUVB SEC FilingsNuvation Bio Inc 10-K, 10-Q, 8-K Forms - Stock Titan

Jun 28, 2025
pulisher
Jun 25, 2025

Nuvation Bio stock rating reiterated at Market Outperform by Citizens JMP - Investing.com South Africa

Jun 25, 2025
pulisher
Jun 24, 2025

Nuvation Bio's Taletrectinib Emerges as a Niche Oncology Leader with NCCN Endorsement - AInvest

Jun 24, 2025
pulisher
Jun 24, 2025

Nuvation Bio (NUVB) Gains NCCN Endorsement for Taletrectinib in - GuruFocus

Jun 24, 2025
pulisher
Jun 24, 2025

Nuvalent chases after Nuvation in ROS1 lung cancer - pharmaphorum

Jun 24, 2025
pulisher
Jun 22, 2025

Nuvation Bio's Mysterious 10% Surge: A Technical & Market Flow Deep Dive - AInvest

Jun 22, 2025
pulisher
Jun 20, 2025

Nuvation Bio jumps after insiders purchase shares worth over $1.1M - MSN

Jun 20, 2025
pulisher
Jun 20, 2025

Nuvation Bio’s Mysterious 7% Surge: What’s Behind the Volatility? - AInvest

Jun 20, 2025
pulisher
Jun 19, 2025

Wealth Enhancement Advisory Services LLC Buys Shares of 10,140 Nuvation Bio Inc. (NYSE:NUVB) - Defense World

Jun 19, 2025
pulisher
Jun 18, 2025

Insider Buying: Stacy Markel Acquires 10,000 Shares of Nuvation Bio Inc (NUVB) - GuruFocus

Jun 18, 2025
pulisher
Jun 18, 2025

Nuvation Bio: A Justified Fall Based On Post-Marketing Requirements (NYSE:NUVB) - Seeking Alpha

Jun 18, 2025
pulisher
Jun 17, 2025

Nuvation Bio (NUVB): RBC Capital Maintains Rating, Lowers Price - GuruFocus

Jun 17, 2025
pulisher
Jun 17, 2025

Nuvation Bio (NUVB): RBC Capital Maintains Rating, Lowers Price Target | NUVB Stock News - GuruFocus

Jun 17, 2025
pulisher
Jun 17, 2025

Nuvation Bio (NUVB) Target Price Revised Amid Commercial Shift | NUVB Stock News - GuruFocus

Jun 17, 2025
pulisher
Jun 17, 2025

RBC Cuts Price Target on Nuvation Bio to $6 From $10, Keeps Outperform, Speculative Risk - MarketScreener

Jun 17, 2025
pulisher
Jun 16, 2025

Onco360 Has Been Selected as a National Specialty Pharmacy Partner for IBTROZI™ (taletrectinib), Manufactured by Nuvation Bio Inc. - The Manila Times

Jun 16, 2025

Nuvation Bio Inc (NUVB) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$23.63
price up icon 3.32%
$36.59
price up icon 1.61%
$103.52
price up icon 0.08%
$27.57
price down icon 1.57%
$114.57
price down icon 0.03%
biotechnology ONC
$296.46
price up icon 0.55%
大文字化:     |  ボリューム (24 時間):